These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 32239476

  • 1. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A, Antillón-Ferreira C, Saavedra-Castillo E, Barrientos-Pérez M, Rivero-Escalante H, Flores-Caloca O, Calzada-León R, Rosas-Guerra CC, Koledova E, Chiquete E, Ayala-Estrada A.
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [Abstract] [Full Text] [Related]

  • 2. Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS).
    Charmandari E, Vlachopapadopoulou E, Kyritsi EM, Sakellariou D, Koledova E, Nespithal K, Michalacos S.
    Growth Horm IGF Res; 2020 Oct; 53-54():101336. PubMed ID: 32739654
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C, Guzzetti C, Orlando G, Loche S, Italian ECOS Investigators.
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [Abstract] [Full Text] [Related]

  • 5. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S, Salerno M, Garofalo P, Cardinale GM, Licenziati MR, Citro G, Caruso Nicoletti M, Cappa M, Longobardi S, Maghnie M, Perrone R.
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Yearly Height Gain Is Dependent on the Truly Received Dose of Growth Hormone and the Duration of Periods of Poor Adherence: Practical Lessons From the French Easypod™ Connect Multicenter Observational Study.
    Coutant R, Nicolino M, Cammas B, de Buyst V, Tauber M, Hamel JF.
    Front Endocrinol (Lausanne); 2021 Dec; 12():790169. PubMed ID: 35126310
    [Abstract] [Full Text] [Related]

  • 8. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O, Snajderova M, Blair J, Pournara E, Pedersen BT, Petit IO.
    Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
    [Abstract] [Full Text] [Related]

  • 9. Monitoring of treatment adherence with easypod™ in six Italian centers: a real-world experience.
    Cardinale GM, Pesce S, Ingletto D, Mariano M, Catucci A, Corciulo N, Fidotti E.
    Minerva Endocrinol; 2019 Sep; 44(3):246-251. PubMed ID: 30482007
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.
    Lundberg E, Kriström B, Zouater H, Deleskog A, Höybye C.
    BMC Endocr Disord; 2020 Apr 29; 20(1):55. PubMed ID: 32349731
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of Growth Hormone Results in Different Diagnosis and Trend Over 10 Year of Follow-up: A Single Center Experience.
    Aycan Z, Araslı Yılmaz A, Yel S, Savaş-Erdeve Ş, Çetinkaya S.
    J Clin Res Pediatr Endocrinol; 2021 Aug 23; 13(3):332-341. PubMed ID: 33749217
    [Abstract] [Full Text] [Related]

  • 13. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL, Lee PA, Gut R, Germak J.
    Growth Horm IGF Res; 2015 Dec 23; 25(6):286-93. PubMed ID: 26363846
    [Abstract] [Full Text] [Related]

  • 14. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A, Daftardar H, Alghamdi AA, Jamjoom M, Awidah S, Ahmed ME, Soliman AT.
    Acta Biomed; 2020 Mar 19; 91(1):29-40. PubMed ID: 32191651
    [Abstract] [Full Text] [Related]

  • 15. The adult growth hormone multicentric retrospective observational study: a 24-month Italian experience of adherence monitoring via Easypod™ of recombinant growth hormone treatment in adult GH deficiency.
    Mancini A, Vergani E, Bruno C, Giavoli C, Spaziani M, Isidori AM, Arosio M, Pontecorvi A.
    Front Endocrinol (Lausanne); 2023 Mar 19; 14():1298775. PubMed ID: 38027149
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial.
    Czepielewski MA, Garret Q, Vencio SAC, Rassi N, Felicio JS, Faria MS, Senn CCP, Bronstein MD, Cerqueira MJAG, Neves ACL, Sgarbi JA, Spinola-Castro AM, Cunha MPR, Bandeira F, Toffoletto O, Afiune J, Baradelli R, Rodrigues DG, Scharf M.
    Growth Horm IGF Res; 2019 Mar 19; 48-49():29-35. PubMed ID: 31493626
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders.
    Hartmann K, Ittner J, Müller-Rossberg E, Schönau E, Stephan R, Ullrich KP, Hoppe B, Ramseger R, Brämswig J.
    Horm Res Paediatr; 2013 Mar 19; 80(1):1-5. PubMed ID: 23860437
    [Abstract] [Full Text] [Related]

  • 18. Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device.
    Assefi AR, Roca F, Rubstein A, Chareca C.
    Front Med Technol; 2021 Mar 19; 3():609878. PubMed ID: 35047902
    [Abstract] [Full Text] [Related]

  • 19. Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
    Pfäffle R, Bidlingmaier M, Kreitschmann-Andermahr I, Land C, Partsch CJ, Schwab KO, Sommer H, Backeljauw P, Kanumakala S, Loche S, Zouater H, Strasburger CJ.
    Horm Res Paediatr; 2020 Mar 19; 93(3):154-163. PubMed ID: 32814319
    [Abstract] [Full Text] [Related]

  • 20. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Mar 19; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.